{"id":52521,"date":"2023-01-04T14:02:37","date_gmt":"2023-01-04T13:02:37","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/rayzebio-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference-on-monday-january-9-2023\/"},"modified":"2023-01-04T14:02:37","modified_gmt":"2023-01-04T13:02:37","slug":"rayzebio-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference-on-monday-january-9-2023","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/rayzebio-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference-on-monday-january-9-2023\/","title":{"rendered":"RayzeBio to Present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023"},"content":{"rendered":"
\n

SAN DIEGO–(BUSINESS WIRE)–RayzeBio, Inc., a targeted radiopharmaceutical company developing an innovative pipeline against validated solid tumor targets, today announced that Ken Song, M.D., President and CEO of the Company, will be presenting at the 41st<\/sup> Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023.\n<\/p>\n

<\/a><\/p>\n

\nJ.P. Morgan Healthcare Conference
\n
<\/b>Date: Monday, January 9, 2023
\n
Time: 2:00 p.m. – 2:25 p.m. PST
\n
Location: The Westin St. Francis \u2013 Golden Gate Room\n<\/p>\n

\nAbout RayzeBio<\/b>\n<\/p>\n

\nRayzeBio is a biotechnology company focused on improving outcomes for people with cancer by harnessing the power of targeted radioisotopes. With a focus on clinically validated solid tumor targets, RayzeBio is developing novel drug conjugates to deliver potent therapeutic radioisotopes such as Actinium-225, an alpha-emitter. The company is backed by a syndicate of sophisticated healthcare investors and was established in 2020. For additional information, please visit www.rayzebio.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nArvind Kush
\n
info@rayzebio.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SAN DIEGO–(BUSINESS WIRE)–RayzeBio, Inc., a targeted radiopharmaceutical company developing an innovative pipeline against validated solid tumor targets, today announced that Ken Song, M.D., President and CEO of the Company, will be presenting at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023. J.P. Morgan Healthcare Conference Date: Monday, January 9, 2023 Time: … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52521","6":"format-standard","7":"category-industry"},"yoast_head":"\nRayzeBio to Present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/rayzebio-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference-on-monday-january-9-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RayzeBio to Present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO–(BUSINESS WIRE)–RayzeBio, Inc., a targeted radiopharmaceutical company developing an innovative pipeline against validated solid tumor targets, today announced that Ken Song, M.D., President and CEO of the Company, will be presenting at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023. J.P. Morgan Healthcare Conference Date: Monday, January 9, 2023 Time: ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/rayzebio-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference-on-monday-january-9-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-04T13:02:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230104005346\/en\/1676285\/21\/RayzeBio_Logo_RGB.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rayzebio-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference-on-monday-january-9-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rayzebio-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference-on-monday-january-9-2023\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"RayzeBio to Present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023\",\"datePublished\":\"2023-01-04T13:02:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rayzebio-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference-on-monday-january-9-2023\\\/\"},\"wordCount\":161,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rayzebio-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference-on-monday-january-9-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230104005346\\\/en\\\/1676285\\\/21\\\/RayzeBio_Logo_RGB.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rayzebio-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference-on-monday-january-9-2023\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rayzebio-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference-on-monday-january-9-2023\\\/\",\"name\":\"RayzeBio to Present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rayzebio-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference-on-monday-january-9-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rayzebio-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference-on-monday-january-9-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230104005346\\\/en\\\/1676285\\\/21\\\/RayzeBio_Logo_RGB.jpg\",\"datePublished\":\"2023-01-04T13:02:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rayzebio-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference-on-monday-january-9-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rayzebio-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference-on-monday-january-9-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rayzebio-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference-on-monday-january-9-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230104005346\\\/en\\\/1676285\\\/21\\\/RayzeBio_Logo_RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230104005346\\\/en\\\/1676285\\\/21\\\/RayzeBio_Logo_RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rayzebio-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference-on-monday-january-9-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"RayzeBio to Present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"RayzeBio to Present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/rayzebio-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference-on-monday-january-9-2023\/","og_locale":"en_US","og_type":"article","og_title":"RayzeBio to Present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 - Pharma Trend","og_description":"SAN DIEGO–(BUSINESS WIRE)–RayzeBio, Inc., a targeted radiopharmaceutical company developing an innovative pipeline against validated solid tumor targets, today announced that Ken Song, M.D., President and CEO of the Company, will be presenting at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023. J.P. Morgan Healthcare Conference Date: Monday, January 9, 2023 Time: ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/rayzebio-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference-on-monday-january-9-2023\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-04T13:02:37+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230104005346\/en\/1676285\/21\/RayzeBio_Logo_RGB.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/rayzebio-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference-on-monday-january-9-2023\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/rayzebio-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference-on-monday-january-9-2023\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"RayzeBio to Present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023","datePublished":"2023-01-04T13:02:37+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/rayzebio-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference-on-monday-january-9-2023\/"},"wordCount":161,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/rayzebio-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference-on-monday-january-9-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230104005346\/en\/1676285\/21\/RayzeBio_Logo_RGB.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/rayzebio-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference-on-monday-january-9-2023\/","url":"https:\/\/pharma-trend.com\/en\/rayzebio-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference-on-monday-january-9-2023\/","name":"RayzeBio to Present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/rayzebio-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference-on-monday-january-9-2023\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/rayzebio-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference-on-monday-january-9-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230104005346\/en\/1676285\/21\/RayzeBio_Logo_RGB.jpg","datePublished":"2023-01-04T13:02:37+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/rayzebio-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference-on-monday-january-9-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/rayzebio-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference-on-monday-january-9-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/rayzebio-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference-on-monday-january-9-2023\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230104005346\/en\/1676285\/21\/RayzeBio_Logo_RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230104005346\/en\/1676285\/21\/RayzeBio_Logo_RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/rayzebio-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference-on-monday-january-9-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"RayzeBio to Present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52521","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52521"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52521\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52521"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52521"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52521"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}